Content
ClinicalTrials.gov is the best public starting point for understanding a Mood Institute study. Begin with the study identifier, then read the official title, brief summary, recruitment status, and listed locations. For Mood Institute, NCT06713616 and NCT06725277 are the relevant public listings. Because registry information can be updated, the current listing should be treated as the public source of record.
Read the study objective before focusing on individual terms. The objective explains the broad question the study is designed to examine. One listing describes comparative-effectiveness work involving racemic ketamine and esketamine, marketed as SPRAVATO®, in depression; the other describes an observational study of real-world care. This language provides study context. It does not recommend an option to a reader or establish that someone can join a study.
Next, check the recruitment status and locations. Status labels can help you understand whether the registry currently describes a study as recruiting, active, completed, or in another stage. The listed locations show where study activities may occur. If the information is unclear or has changed since you last looked, write down the study number and ask the research team to explain the current public listing.
The eligibility section may contain study criteria, but it should be read as a description of the protocol rather than a self-screening checklist. A familiar diagnosis, prior treatment, age range, or phrase in the registry does not confirm enrollment. Screening occurs separately with the research team, using the study's established process and a private channel for personal information.
Use the listing to prepare three questions: What is the study trying to learn? What does the public description say about visit expectations? What is the current status at the Milford location? Then contact the research team with the study identifier, NCT06713616 or NCT06725277, and your general questions. Keep personal health details out of Mood Guide and general contact fields.